Related Experiment Video
Updated: Aug 24, 2026

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
Racial differences in survival among men with prostate cancer and comorbidity at time of diagnosis
Vincent L Freeman1, Ramon Durazo-Arvizu, LaShon C Keys
1Midwest Center for Health Services and Policy Research, Edward Hines Jr. VA Hospital, PO Box 5000 (151 H), Hines, IL 60141, USA. freeman@research.hines.med.va.gov
Insights
Black men with prostate cancer face higher mortality, but this disparity lessens with increased comorbidity at diagnosis. Absence of significant medical conditions at diagnosis is linked to greater excess mortality risk in Black men.
Area of Science:
- Oncology
- Epidemiology
- Health Disparities
Background:
- Prostate cancer survival rates exhibit racial disparities.
- Comorbidity at diagnosis is a crucial factor influencing cancer outcomes.
- Understanding factors affecting survival is vital for targeted interventions.
Purpose of the Study:
- To investigate the impact of comorbidity on racial differences in prostate cancer survival.
- To determine if comorbidity modifies the association between race and mortality.
- To identify specific patient characteristics associated with increased mortality risk.
Main Methods:
- Retrospective analysis of 864 prostate cancer patients diagnosed between 1986-1990.
- Comorbidity assessment using the Charlson index based on clinical data.
- Cox proportional hazards models used to compare cause-specific relative mortality, adjusted for covariates.
Main Results:
- Black patients demonstrated significantly higher mortality from prostate cancer and other causes compared to White patients.
- The observed racial survival differences diminished as initial comorbidity scores increased.
- Patients with a Charlson score of 0 had a relative risk of 1.75, while those with scores >=5 had a risk of 0.90.
Conclusions:
- The absence of significant pre-existing medical conditions at diagnosis is associated with a higher risk of excess mortality among Black men with prostate cancer.
- Comorbidity plays a significant role in mitigating racial disparities in prostate cancer survival.
- Further research is needed to elucidate the mechanisms behind these disparities and inform clinical practice.
Objectives:
This study evaluated the effect of comorbidity at diagnosis on racial differences in survival among men with prostate cancer.
Methods:
Clinical and demographic data were abstracted from records of 864 patients diagnosed at 4 Chicago area hospitals between 1986 and 1990. Comorbidity was scored on the basis of clinical information in the Charlson index. Cause-specific relative mortality adjusted for age, stage, differentiation, and treatment was compared across Charlson scores with Cox proportional hazards functions.
Results:
Blacks had significantly greater mortality from prostate cancer and other causes (vs Whites, relative risk [95% confidence interval] = 1.84 [1.22, 2.79] and 1.69 [1.33, 2.29], respectively; P <.001). However, differences disappeared as initial comorbidity increased (1.75 [1.33, 2.31] vs 0.90 [0.59, 1.29] for scores = 0 and > or =5, respectively).
Conclusions:
Absence of a significant preexisting medical diagnosis is associated with a higher risk for excess mortality among Black men diagnosed with prostate cancer.
Related Concept Videos
Comparing the Survival Analysis of Two or More Groups
Cancer Survival Analysis
Disorders of the Male Reproductive System
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...
The Mantel-Cox Log-Rank Test
